A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

6.1K views

DOI:

10.3791/59449

May 22nd, 2019

In This Article

Summary

Here, we describe a protocol to generate a viable female murine model with non-random X chromosome inactivation, i.e., the maternally-inherited X chromosome is inactive in 100% of the cells. We also describe a protocol to test feasibility, tolerability, and safety of pharmacological reactivation of the inactive X chromosome in vivo.

Abstract

X chromosome inactivation (XCI) is the random silencing of one X chromosome in females to achieve gene dosage balance between the sexes. As a result, all females are heterozygous for X-linked gene expression. One of the key regulators of XCI is Xist, which is essential for the initiation and maintenance of XCI. Previous studies have identified 13 trans acting X chromosome inactivation factors (XCIFs) using a large-scale, loss-of-function genetic screen. Inhibition of XCIFs, such as ACVR1 and PDPK1, using short-hairpin RNA or small molecule inhibitors, reactivates X chromosome-linked genes in cultured cells. But the feasibility and tolerability of reactivating the inactive X chromosome in vivo remains to be determined. Towards this goal, a XistΔ:Mecp2/Xist:Mecp2-Gfp mouse model has been generated with non-random XCI due to deletion of Xist on one X chromosome. Using this model, the extent of inactive X reactivation was quantitated in the mouse brain following treatment with XCIF inhibitors. Recently published results show, for the first time, that pharmacological inhibition of XCIFs reactivates Mecp2 from the inactive X chromosome in cortical neurons of the living mouse brain.

Introduction

X chromosome inactivation (XCI) is a process of dosage compensation that balances X-linked gene expression by silencing one copy of the X chromosome in females1. As a result, the inactive X chromosome (Xi) accumulates characteristic features of heterochromatin including DNA methylation and inhibitory histone modifications, such as histone H3-lysine 27 trimethylation (H3K27me3) and histone H2A ubiquitination (H2Aub)2. The master regulator of X chromosome silencing is the X-inactivation center (Xic) region, around 100−500 kb, which controls the counting and pairing of the X chromosomes, the random choice of the X chr....

Access restricted. Please log in or start a trial to view this content.

Protocol

Work involving mice was approved by the University of Virginia Institutional Animal Care and Use Committee (IACUC; #4112).

1. Generate a Non-random XCI Mouse Model with Genetically Labeled Mecp2 on Xi

NOTE: Mouse strains used in the study were as follows: Mecp2-Gfp/Mecp2-Gfp (Mecp2tm3.1Bird, Table of Materials) and Xist/ΔXist (B6;129-Xist<tm5Sado>; provided by Antonio Bedalov, Fred Hutchinson Cancer Center, Seattle). Breeding strategies among the respective strains have been designed to expand the mouse colonies f....

Access restricted. Please log in or start a trial to view this content.

Results

To demonstrate the feasibility of the XistΔ:Mecp2/Xist:Mecp2-Gfp mouse model for Xi reactivation studies, XCIF inhibitor-mediated reactivation of Xi-linked Mecp2-Gfp was tested in mouse embryonic fibroblasts (MEFs). Female MEFs were isolated from day 15.5 XistΔ:Mecp2/Xist:Mecp2-Gfp embryos as described in section 3 (Figure 1A). The genotypes of female XistΔ:Mecp2/Xist:Mecp2-Gfp MEFs were confirmed by genotyping-PCR, as described previou.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Previously, XCIFs that are selectively required for silencing of Xi-linked genes in mammalian female cells were identified12. We further optimized potent small molecule inhibitors to target XCIFs, such as ACVR1 and downstream effectors of PDPK1, which efficiently reactivate Xi-linked Mecp2 in mouse fibroblast cell lines, mouse cortical neurons, and a human fibroblast cell line derived from a RTT patient. These results suggest that Xi reactivation is a plausible therapeutic approach to res.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors thank Antonio Bedalov for providing reagents; University of Virginia Tissue Histology Core for cryosectioning; University of Virginia Flow Cytometry Core for flow cytometry analysis; Christian Blue and Saloni Singh for technical assistance with genotyping. This work was supported by a Double Hoo Research Grant to Z.Z., and a Pilot Project Program Award from the University of Virginia-Virginia Tech Seed Fund Award and the Hartwell Foundation Individual Biomedical Research Award to S.B.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
MICE
Mecp2tm3.1BirdThe Jackson Laboratory#014610
B6;129-Xist (tm5Sado)provided by Antonio Bedalov, Fred Hutchinson Cancer Center, Seattle
REAGENTS
22x22 mm coverslipFISHERfinest (Fisher Scientific)125488
32% ParaformaldehydeElectron Microscopy Sciences15714-S
50 ml syringeMedline IndustriesNPMJD50LZ
60mm culture dishCellStar628160
7-AAD BioLegend420403
ammonium chloride (NH4Cl)Fisher ChemicalA661-3
anti-GFP-AlexaFluor647InvitrogenA-31852
anti-MAP2Aves LabsMAP
BSAPromegaR396D
Buprenorphine SRZoopharm
citric acid SigmaC-1857
DMSOFisher BioreagentsBP231-100
Dulbecco's Modified Eagle Medium (DMEM)Corning Cellgro10-013-CV
EthanolDecon Labs2701
fetal bovine serum (FBS)VWR Life Science89510-198
gelatinSigma-AldrichG9391
glass slidesFisherbrand22-034-486
goat anti-chicken FITC-labeled secondary antibody Aves LabsF-1005
GSK650394ApexBioB1051
hamilton 10μl syringe Hamilton Sigma-Aldrich28615-U
Hank's Balanced Salt Solution (HBSS)Gibco14025-092
KetamineKetasetNDC 0856-2013-01
Large blunt/blunt curved scissorsFine Science Tools14519-14
LDN193189Cayman Chemicals11802
lodixanolSigma1343517
magnesium chloride (MgCl2)Fisher ChemicalM35-212
MethylceluloseSigmaM0262-100G
mounting medium with DAPI VectashieldH-1200
Needle tip, 26 GA x 1.25"PrecisionGlide305111
ophthalmic ointment Refresh Lacri-Lube93468
optimal cutting temperature (O.C.T.) ThermoFisher
PCR mix
Penicillin/Streptomycin (Pen/Strep)Corning30-002-Cl
Phosphate buffered saline pH 7.4 (PBS)Corning Cellgro46-103-CM
Potassium chloride (KCl)Fisher ScientificP330-500
scalpel blades
Shallow glass or plastic tray
skin glue/tissue adhesive3M Vetbond1469SB
sodium azideFisher ScientificCAS 26628-22-8
Sodium chloride (NaCl)Fisher ChemicalS642-212
standard hemostat forcepsFine Science Tools13013-14
Standard tweezersFine Science Tools11027-12
Straight iris scissorsFine Science Tools14058-11
sucroseFisher ScientificBP220-1
Tris-baseFisher BioreagentsBP152-5
Triton X-100Fisher BioreagentsBP151-500
Trypsin-EDTA Gibco15400-054
XylazineAkornNDC: 59399-111-50
EQUIPMENT
Zeiss AxioObserver Live-Cell microscope ZeissZeiss AxioObserver
0.45mm burrIDEAL MicroDrill67-1000
BD FACScalibur
centrifuge
glass homogenizer
cell culture incubatorThermo Scientific HERACELL VIOS 160i13-998-213
Leica 3050S research cryostat
stereotactic platform
thermocycler
Timer
ultracentrifugeBeckman Coulter Optima L-100 XP
Water bath (37 ºC)Fisher Scientific Isotemp 2239

References

  1. Lyon, M. F. X-chromosome inactivation as a system of gene dosage compensation to regulate gene expression. Progress in Nucleic Acid Research and Molecular Biology. 36, 119-130 (1989).
  2. Heard, E.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

X Chromosome InactivationMecp2 ReactivationStereotactic InjectionXCIF InhibitorsBrain Tissue ProcessingImmunofluorescence StainingFlow Cytometry AnalysisGFP-tagged Mecp2